Advanced Cardiac Therapeutics

13 articles about Advanced Cardiac Therapeutics

• Advanced Cardiac Therapeutics, Inc. Changes Name to EPIX Therapeutics, Inc.

  8/13/2018

  Announces FDA Approval to Begin Enrolling Persistent Atrial Fibrillation Subjects in Global IDE Study to Evaluate the DiamondTemp™ Ablation System

• Bay Area's Advanced Cardiac Therapeutics Snags $45 Million to Advance Innovative Treatment for Heart Disease

  5/2/2017

• Advanced Cardiac Therapeutics Successfully Completes Clinical Trial Enrollment

  3/28/2016

• Advanced Cardiac Therapeutics Completes Successful First In Man

  1/26/2016

• Advanced Cardiac Therapeutics Announces New Financing For Next Generation Temperature-Sensing Cardiac Ablation Catheter For Treatment Of Cardiac Arrhythmias

  4/21/2014

• Advanced Cardiac Therapeutics Announces Positive Data Supporting Its Unique Real-Time Temperature Sensing System at 2012 Heart Rhythm Society Meeting

  5/23/2012

• Advanced Cardiac Therapeutics Announces Several Key Appointments

  5/7/2012

• Advanced Cardiac Therapeutics Announces Presentations at 2012 Heart Rhythm Society Meeting

  5/7/2012

• U.S. Granted Patent 8,088,385 B2 Strengthens Advanced Cardiac Therapeutics' Anti-Cancer Product Portfolio

  4/3/2012

• Advanced Cardiac Therapeutics Announces CE Mark Clearance for Innovative Catheter System for the Treatment of Atrial Arrhythmias

  6/8/2011

• Roy T. Tanaka Joins Board of Directors of Advanced Cardiac Therapeutics

  4/11/2011

• Advanced Cardiac Therapeutics Initiates First-In-Man CE Mark Clinical Trial to Study Innovative Catheter System for the Treatment of Atrial Arrhythmias

  3/17/2011

• Advanced Cardiac Therapeutics Completes $5 Million Financing New Financing to Support Completion and Launch of Innovative Ablation Catheter System Advancing Lesion Control

  1/11/2010